20160128 EGA Regulatory and Scientific Affairs Conferenc

The European Biosimilars Group Appoints New Leadership Team With Sandoz’ Carol Lynch and Polpharma’s Klaus Martin

10 February 2016

Last week in Brussels, the European Biosimilar medicines Group (EBG […]

Read more

EGA Welcomes the Delegated Regulation as a Tool To Fight Counterfait Medicines

9 February 2016

Brussels – The European Generic and Biosimilar Medicines Association (EGA) welcomes […]

Read more

Shaping The 2020 Regulatory Landscape For Patient Needs

28 January 2016

London – 61 regulators from 25 countries made progress in improving the […]

Read more

Industry Coming Together To Improve Safety For Patients

26 January 2016

London – In London this week, the European Generic and Biosimilar medicines […]

Read more

Piden fabricar genéricos en periodo de extensión

25 January 2016

El presidente de la EGA considera que actualmente la industria […]

Read more

Global Pharmaceutical Industry Calls on Governments to Work with Them to Beat the Rising Threat of Drug Resistance

21 January 2016

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology […]

Read more

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

21 January 2016

Antimicrobials, and specifically antibiotics, play a crucial role in modern […]

Read more

Spain and Europe Join Forces To Bring Access To Generic Medicines To The Market

19 January 2016

Barcelona – At their joint Executive meeting in Barcelona today, the […]

Read more

Ethics: EGA Adopts Disclosure Requirements For The Generic, Biosimilar And Value Added Medicines Industry

15 January 2016

Brussels – Today, EGA members unanimously adopted disclosure rules for the […]

Read more

Generic and Biosimilar Medicines Essential for Italian Healthcare System

8 January 2016

Brussels – Generic and biosimilar medicines represent an essential opportunity to […]

Read more

Subscribe to our newsletter